SIMULTANEOUS QUANTIFICATION, METHOD DEVELOPMENT AND METHOD VALIDATION FOR LOSARTAN POTASSIUM AND ENALAPRIL MALEATE IN SOLID DOSAGE FORM BY RP-HPLC

Read full text Summarise with VIRAT
Authors: S. Teja1*, A. Kanaka Durga Valli2, P. Prathyusha3, K. Bindu Latha4, M. Sravanthi5
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Analytical Method Validation is crucial in pharmaceutical research and manufacturing process. Losartan Potassium and Enalapril Maleate Peaks were well resolved at retention times 9.604 and 2.604 min respectively for 1ml/min flow rate in isocratic mode at a run time of 15 min with Welchrom 250mm x 4.6mm, 5µm column & Ammonium acetate buffer: water: methanol (10:30:60) as mobile phase at 226nm. % Assay values were 99.52% and 99.15% for Losartan potassium and Enalapril maleate respectively. Linearity was produced in the range of 24-72 ppm for Losartan Potassium and 20-60 ppm for Enalapril Maleate with a correlation coefficient of 0.9993 & 0.9998 respectively. The new approach was verified using ICH requirements and found to be specific, sensitive, precise, reliable, and linear. The suggested approach may successfully estimate Losartan Potassium and Enalapril Maleate in marketed formulations.

Fields of Study & Subjects

Analytical Methods in Pharmaceuticals Analytical Chemistry and Chromatography Traditional Chinese Medicine Analysis

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
1 April 2026
Language
EN